Do I Qualify?
Punit Dhillon's avatarPerson

Punit Dhillon

President, CEO and ChairSkye Bioscience Inc.

San Diego Area

Member Since June 2021

Skills

Biotechnology
Biopharmaceuticals
Leadership

About

Punit Dhillon is the Chairman and CEO of Skye Bioscience Inc., a public pharmaceutical company. He is the Co-founder, former President, and CEO of OncoSec, a biotechnology company pioneering new technologies to fight cancer, and the Co-founder of the registered charity, YELL Canada. Punit has been recognized as one of PharmaVOICE 100’s top CEOs and as a finalist for the EY Entrepreneur Of The Year™. He lives in San Diego with his wife, Nina, and their two daughters.

Published content

Flaws Don’t Make Leaders Look Bad—Hiding Them Does

article

If you’ve ever lost sleep over a fear of “looking bad,” take a page from the sports world: reflect on your flaws and create a plan to improve them.

‘Fake It’ and You Might Never Make It

article

In the business world, it’s not always easy to recognize when “faking it” crosses the line.

Why Dominating Your Field Is a Marathon, Not a Sprint

article

What leaders at the most successful companies in the world have realized is that dominating your field over a long period requires a similarly long-term perspective. 

How to Stay Competitive Without Letting Comparisons Become a Distraction

article

As a leader, it’s up to you to coach your team to victory.

Don't Let Past Mistakes Hold You Back From Future Successes

article

Whether in athletics, work or life, not everything you do will end in a podium finish.

3 Steps to Get Your Business Back on Track After the Pandemic

article

Don’t miss the opportunity to plan now to prepare for the next crisis.

Company details

Skye Bioscience Inc.

Company bio

We are a biopharmaceutical company engineering proprietary cannabinoid derivatives to treat glaucoma and other diseases with significant unmet medical needs. Our innovative approach to drug development enables us to transform cannabinoids into safer, more effective pharmaceutical agents. By advancing our novel drugs, we are working to bring important new medicines to market by unlocking the potential of cannabinoids.

Industry

Technology

Company size

2 - 10

This member is no longer active.

Are you a business founder with a passion for influencing culture?

Click below to learn more about membership and publication opportunities on RollingStone.com.
Check out the CommunityDo I Qualify?
Rolling Stone Culture Council is a vetted professional network of influential business leaders in the music, entertainment, media, food & beverage, fashion, sports, gaming and cannabis industries.